iNtRON Biotechnology, Inc. (KOSDAQ:048530)
South Korea · Delayed Price · Currency is KRW 3,640.00
-25.00 (-0.68%)
Feb 19, 2026, 12:30 PM KST
iNtRON Biotechnology Market Cap
iNtRON Biotechnology has a market cap or net worth of 112.35 billion as of February 18, 2026. Its market cap has decreased by -38.90% in one year.
Market Cap
112.35B
Enterprise Value
77.42B
Revenue
5.56B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,640.00
Market Cap Chart
Since January 26, 2011, iNtRON Biotechnology's market cap has increased from 95.30B to 112.35B, an increase of 17.89%. That is a compound annual growth rate of 1.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 112.35B | 9.35% |
| Dec 30, 2025 | 102.75B | -44.03% |
| Dec 30, 2024 | 183.56B | -37.01% |
| Dec 28, 2023 | 291.42B | 7.98% |
| Dec 29, 2022 | 269.88B | -61.99% |
| Dec 30, 2021 | 710.00B | -22.41% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HLB Therapeutics | 240.96B |
| Genexine | 201.02B |
| MedPacto | 200.85B |
| Macrogen | 195.80B |
| ENCell | 183.11B |
| GeneOne Life Science | 140.58B |
| IMB Dx | 114.53B |
| CG Invites | 103.12B |